The UK BIA Antibody Taskforce, of which the University of Oxford is a member, is a leading UK consortium developing antibodies for treating COVID-19. The Taskforce has reached a major milestone - the identification of differentiated antibody combinations that will be taken forward for further development as an antibody “cocktail”. The Taskforce developed an accelerated and rigorous multifaceted approach to create a pool of over 600 novel candidates and identified a set of antibodies with the greatest potential.
The full story is available on the The UK BioIndustry Association website